Pemafibrate Ameliorates Steatotic Liver Disease Regardless of Endothelial Dysfunction in Mice - Hara, Tomoyo; Yamagami, Hiroki; Uemoto, Ryoko; Sekine, Akiko; Kaneko, Yousuke; Miyataka, Kohsuke; Hori, Taiki; Ichimura-Shimizu, Mayuko; Funamoto, Masafumi; Harada, Takeshi; Yuasa, Tomoyuki; Nakamura, Shingen; et al. (Antioxidants, 2025)
Keywords: 4-Hydroxynonenal; Animal models; Automation; Cholesterol; Control; Dosage and administration; Drinking water; endothelial dysfunction; eNOS; Fatty acids; Fibric acids; Gene expression; Health aspects; High cholesterol diet; High fat diet; Immunohistochemistry; Laboratories; Liver diseases; Macrophages; MASLD; NAD(P)H oxidase; NADPH oxidase; Nitric-oxide synthase; Oxidation; Oxidative stress; Pathogenesis; Pathology; pemafibrate; Physiological aspects; Plasma; Proteins; Japan; United States--US; Germany; pemafibrate; eNOS; MASLD; endothelial dysfunction; NADPH oxidase; oxidative stress